NEFL and amyotrophic lateral sclerosis: Serum neurofilament light chain (sNfL) seems to comply with the requirement for a reliable biomarker for ALS as it is closely correlated with prognosis, even at first diagnostic referral, and accurately help distinguishing between ALS and its main differential diagnoses.3, 4, 5